Oxford spinout Optellum secures $14m funding to advance pioneering AI-powered lung cancer diagnosis technology

Published on October 3, 2022


Optellum, a University of Oxford spinout that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round.